Effect On Disability Measures And Msfc In Patients With Relapsing Multiple Sclerosis From The Phase 3 Ponesimod Versus Teriflunomide Optimum Study
MULTIPLE SCLEROSIS JOURNAL(2020)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
MULTIPLE SCLEROSIS JOURNAL(2020)